ALIMERA SCIENCES
Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company is passionate about protecting the retina and developing innovative treatments to preserve vision.
ALIMERA SCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Alpharetta, Georgia, United States
Country:
United States
Website Url:
http://www.alimerasciences.com
Total Employee:
51+
Status:
Active
Contact:
+1 678 990 5740
Email Addresses:
[email protected]
Total Funding:
304.35 M USD
Technology used in webpage:
Amazon HSTS IPv6 Apple Mobile Web App Capable CloudFront GoDaddy SSL Elementor IIS 8 Elementor Pro Amazon Frankfurt Region
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
AOBiome
AOBiome is a life sciences company that focuses on transforming human health.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ocumension Therapeutics
Ocumension Therapeutics investment in Post-IPO Equity - Alimera Sciences
Federal Government
Federal Government investment in Post-IPO Debt - Alimera Sciences
Deerfield
Deerfield investment in Post-IPO Equity - Alimera Sciences
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Alimera Sciences
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Alimera Sciences
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Alimera Sciences
Palo Alto Investors
Palo Alto Investors investment in Post-IPO Equity - Alimera Sciences
Domain Associates
Domain Associates investment in Series C - Alimera Sciences
Polaris Partners
Polaris Partners investment in Series C - Alimera Sciences
Intersouth Partners
Intersouth Partners investment in Series C - Alimera Sciences
Key Employee Changes
Official Site Inspections
http://www.alimerasciences.com Semrush global rank: 646.91 K Semrush visits lastest month: 48.81 K
- Host name: cloudhost-63201.uk-south-2.nxcli.net
- IP address: 165.84.219.3
- Location: Byfleet United Kingdom
- Latitude: 51.3388
- Longitude: -0.474
- Timezone: Europe/London
- Postal: KT14
More informations about "Alimera Sciences"
ABOUT - Alimera Sciences Inc.
At Alimera we believe in finding a way to succeed in everything we do. We’re constantly inspired to find a way by being patient-centric, collaborative, motivated, resourceful and accountable.See details»
HOME - Alimera Sciences Inc.
We see more as an organization — one of us is never as valuable as ALL of us. Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians …See details»
Alimera - LinkedIn
Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer.See details»
Alimera Sciences - Wikipedia
Alimera was founded in June 2003 by Dan Myers, Daniel White, Dave Holland and Mark Testerman. Three of the founders were previously part of Ciba Vision Ophthalmics, which was renamed Novartis Ophthalmics following a merger. In 2004, Alimera Sciences introduced Soothe emollient (lubricant) eye drops for people with dry eyes. Soothe was the first lubricant eye drop to feature Restoryl, a lipid restorative that works t…See details»
COMPANY HIGHLIGHTS - Alimera Sciences Inc.
In 2015, we launched ILUVIEN in the United States f or the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically …See details»
Alimera Sciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 678 990 5740 Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health …See details»
Alimera Sciences, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alimera Sciences, Inc. of Alpharetta, GA. Get the latest business insights from Dun & Bradstreet.See details»
About - Alimera Sciences
Our vision. Our mission. Our Vision is for Alimera to be synonymous with good retinal health. We are a company of people with a passion for protecting the retina to preserve vision. People …See details»
Alimera Sciences Org Chart + Executive Team - The Official Board
The organizational chart of Alimera Sciences displays its 8 main executives including Steve MorrisSee details»
Alimera Sciences Company Profile | Management and Employees …
SQL International Organization for Standardization . PHP PHP . Other Communication and Collaboration Software (4 Technologies) Microsoft Excel Microsoft . ...See details»
Alimera Sciences | UK
Adverse events should also be reported to Alimera Sciences: [email protected]. Report a compliance concern. You may report a …See details»
ALIMERA EXHIBITS CONTINUED GROWTH AND EXPANSION WITH …
Www.alimerasciences.com Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining …See details»
ANI Pharmaceuticals to Further Expand Rare Disease Business
Jun 24, 2024 --ANI Pharmaceuticals, Inc. and Alimera Sciences, Inc. today announced they have signed a definitive agreement pursuant to which ANI will acquire Alimera for $5.50 per …See details»
Alimera Sciences Announces Agreement to Extend Amortization …
ATLANTA, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, …See details»
CONTACT - Alimera Sciences Inc.
Alimera Sciences Limited Sucursal em Portugal Av. D. João II, nº20 – 1º Edifício 7 Mares Parque das Nações 1990-095 Lisboa Portugal. Phone: +351 21 1318912See details»
Alimera Sciences | Europe & the Middle East
European Headquarters Alimera Sciences Europe Ltd 77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, D02 VK60, Ireland Tel: + 353 (0) 1 553 0215See details»
Careers - Alimera Sciences
If you receive a job offer by email that seems to come from Alimera Sciences, you can check whether the offer is genuine or not by contacting us via [email protected]. We will …See details»
Innovation - Alimera Sciences
Adverse events should also be reported to Alimera Sciences: [email protected]. Report a compliance concern. You may report a …See details»
COMPLIANCE PROGRAM - Alimera Sciences Inc.
Alimera Sciences, Inc. hereby declares that, to the best of our knowledge, information, and belief, and based upon our good-faith understanding of the statutory requirements, we have, as of …See details»
PRODUCTS - Alimera Sciences Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision …See details»